메뉴 건너뛰기




Volumn 91, Issue 5, 2012, Pages 729-735

Extracorporeal light chain elimination: High cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury

Author keywords

Acute kidney injury; HCO hemodialysis; Light chain elimination; Multiple myeloma; Renal recovery

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; LENALIDOMIDE; MELPHALAN; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN LIGHT CHAIN;

EID: 84861441771     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1383-0     Document Type: Review
Times cited : (41)

References (38)
  • 1
    • 0025294041 scopus 로고
    • Renal failure in multiple myeloma. Pathogenesis and prognostic implications
    • DOI 10.1001/archinte.150.8.1693
    • Alexanian R, Barlogie B, Dixon D (1990) Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med 150:1693-1695 (Pubitemid 20240982)
    • (1990) Archives of Internal Medicine , vol.150 , Issue.8 , pp. 1693-1695
    • Alexanian, R.1    Barlogie, B.2    Dixon, D.3
  • 5
    • 0033851432 scopus 로고    scopus 로고
    • Renal failure in multiple myeloma: Reversibility and impact on the prognosis. Nordic Myeloma Study Group
    • Knudsen LM, Hjorth M, Hippe E (2000) Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol 65:175-181
    • (2000) Eur J Haematol , vol.65 , pp. 175-181
    • Knudsen, L.M.1    Hjorth, M.2    Hippe, E.3
  • 6
    • 0028824562 scopus 로고
    • Patients with multiple myeloma requiring long-term dialysis: Presenting features, response to therapy, and outcome in a series of 20 cases
    • Torra R, Blade J, Cases A, López-Pedret J, Montserrat E, Rozman C et al (1995) Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases. Br J Haematol 91:854-859
    • (1995) Br J Haematol , vol.91 , pp. 854-859
    • Torra, R.1    Blade, J.2    Cases, A.3    López-Pedret, J.4    Montserrat, E.5    Rozman, C.6
  • 7
    • 66449132961 scopus 로고    scopus 로고
    • Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis
    • Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S et al (2009) Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 4:745-754
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 745-754
    • Hutchison, C.A.1    Bradwell, A.R.2    Cook, M.3    Basnayake, K.4    Basu, S.5    Harding, S.6
  • 9
    • 0029564962 scopus 로고
    • Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy
    • Huang ZQ, Sanders PW (1995) Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy. Lab Invest 73:810-817 (Pubitemid 26002340)
    • (1995) Laboratory Investigation , vol.73 , Issue.6 , pp. 810-817
    • Huang, Z.-Q.1    Sanders, P.W.2
  • 10
    • 0035016941 scopus 로고    scopus 로고
    • Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein
    • Ying WZ, Sanders PW (2001) Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein. Am J Pathol 158:1859-1866 (Pubitemid 32422951)
    • (2001) American Journal of Pathology , vol.158 , Issue.5 , pp. 1859-1866
    • Ying, W.-Z.1    Sanders, P.W.2
  • 11
    • 0025020662 scopus 로고
    • Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins
    • Sanders PW, Booker BB, Bishop JB, Cheung HC (1990) Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest 85:570-576 (Pubitemid 20070067)
    • (1990) Journal of Clinical Investigation , vol.85 , Issue.2 , pp. 570-576
    • Sanders, P.W.1    Booker, B.B.2    Bishop, J.B.3    Cheung, H.C.4
  • 12
    • 84862643982 scopus 로고
    • Pathobiology of cast nephropathy from human Bence Jones proteins
    • Sanders PW, Booker BB (1991) Pathobiology of cast nephropathy from human Bence Jones proteins. N Engl J Med 324:1845-1851
    • (1991) N Engl J Med , vol.324 , pp. 1845-1851
    • Sanders, P.W.1    Booker, B.B.2
  • 13
    • 22144499583 scopus 로고    scopus 로고
    • Renal, hematologic and infectious complications in multiple myeloma
    • DOI 10.1016/j.beha.2005.01.013, PII S1521692605000149
    • Blade J, Rosinol L (2005) Renal, hematologic and infectious complications in multiple myeloma. Best Pract Res Clin Haematol 18:635-652 (Pubitemid 40984119)
    • (2005) Best Practice and Research: Clinical Haematology , vol.18 , Issue.4 SPEC. ISS. , pp. 635-652
    • Blade, J.1    Rosinol, L.2
  • 14
    • 77957835828 scopus 로고    scopus 로고
    • Differential progression of renal scarring and determinants of late recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney
    • Basnayake K, Cheung CK, Sheaff M, Fuggle W, Kamel D, Nakoinz S et al (2010) Differential progression of renal scarring and determinants of late recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. J Clin Pathol 63:884-887
    • (2010) J Clin Pathol , vol.63 , pp. 884-887
    • Basnayake, K.1    Cheung, C.K.2    Sheaff, M.3    Fuggle, W.4    Kamel, D.5    Nakoinz, S.6
  • 15
    • 77950270513 scopus 로고    scopus 로고
    • Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or lightchain deposit disease: An ERA-EDTA Registry Study
    • Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J et al (2010) Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or lightchain deposit disease: an ERA-EDTA Registry Study. Nephrol Dial Transplant 25:1200-1206
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1200-1206
    • Tsakiris, D.J.1    Stel, V.S.2    Finne, P.3    Fraser, E.4    Heaf, J.5    De Meester, J.6
  • 17
    • 73249146496 scopus 로고    scopus 로고
    • Lenalidomide plus high-dose dexamathasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: An open-label randomised controlled trial
    • Rajkumar SV, Jacobus S, Callander NS, Fonseca R, Vesole DH, Williams ME et al (2010) Lenalidomide plus high-dose dexamathasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol 11:29-37
    • (2010) Lancet Oncol , vol.11 , pp. 29-37
    • Rajkumar, S.V.1    Jacobus, S.2    Callander, N.S.3    Fonseca, R.4    Vesole, D.H.5    Williams, M.E.6
  • 18
    • 79951891171 scopus 로고    scopus 로고
    • Renal impairment in patients with multiple myeloma: A consensus statement on behalf of the International Myeloma Working Group
    • Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S et al (2010) Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 28:4976-4984
    • (2010) J Clin Oncol , vol.28 , pp. 4976-4984
    • Dimopoulos, M.A.1    Terpos, E.2    Chanan-Khan, A.3    Leung, N.4    Ludwig, H.5    Jagannath, S.6
  • 19
    • 0025269491 scopus 로고
    • Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy
    • DOI 10.1001/archinte.150.4.863
    • Johnson WJ, Kyle RA, Pineda AA, O'Brien PC, Holley KE (1990) Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis and chemotherapy. Arch Intern Med 150:863-869 (Pubitemid 20122064)
    • (1990) Archives of Internal Medicine , vol.150 , Issue.4 , pp. 863-869
    • Johnson, W.J.1    Kyle, R.A.2    Pineda, A.A.3    O'Brien, P.C.4    Holley, K.E.5
  • 20
  • 21
    • 84862673003 scopus 로고    scopus 로고
    • Effective light chain elimination via a high cut-off protein permeable filter in patients with light chain myeloma disease
    • Weisel KC, Heyne N, Hutchison CA, Göhl H, Risler T, Kanz L (2007) Effective light chain elimination via a high cut-off protein permeable filter in patients with light chain myeloma disease. Onkologie 30(suppl 3):80
    • (2007) Onkologie , vol.30 , Issue.SUPPL. 3 , pp. 80
    • Weisel, K.C.1    Heyne, N.2    Hutchison, C.A.3    Göhl, H.4    Risler, T.5    Kanz, L.6
  • 23
    • 10244236377 scopus 로고    scopus 로고
    • Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group
    • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 8:R204-R212
    • (2004) Crit Care , vol.8
    • Bellomo, R.1    Ronco, C.2    Kellum, J.A.3    Mehta, R.L.4    Palevsky, P.5
  • 24
    • 34247235247 scopus 로고    scopus 로고
    • Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury
    • Mehta RL, Kellum JA, Shah SV (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31
    • (2007) Crit Care , vol.11
    • Mehta, R.L.1    Kellum, J.A.2    Shah, S.V.3
  • 25
    • 0036842964 scopus 로고    scopus 로고
    • Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: Validity of a new (MDRD) prediction equation
    • Verfoord G, Willems HL, Wetzels JF (2002) Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant 17:1909-1913 (Pubitemid 35277086)
    • (2002) Nephrology Dialysis Transplantation , vol.17 , Issue.11 , pp. 1909-1913
    • Vervoort, G.1    Willems, H.L.2    Wetzels, J.F.M.3
  • 27
    • 0036176161 scopus 로고    scopus 로고
    • Executive summary
    • Kidney Disease Outcomes Quality Initiative (K/DOQI)
    • Kidney Disease Outcomes Quality Initiative (K/DOQI) (2002) Executive summary. Am J Kidney Dis 39(suppl 1):S17-S31
    • (2002) Am J Kidney Dis , vol.39 , Issue.SUPPL. 1
  • 31
    • 36349025882 scopus 로고    scopus 로고
    • Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma
    • DOI 10.3324/haematol.11463
    • Ludwig H, Drach J, Graf H, Lang A, Meran JG (2007) Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma. Haematologica 92:1411-1414 (Pubitemid 350144160)
    • (2007) Haematologica , vol.92 , Issue.10 , pp. 1411-1414
    • Ludwig, H.1    Drach, J.2    Graf, H.3    Lang, A.4    Meran, J.G.5
  • 32
    • 78049507882 scopus 로고    scopus 로고
    • Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: Results of a phase II study
    • Ludwig H, Adam Z, Hajek R, Greil R, Tóthová E, Keil F et al (2010) Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study. J Clin Oncol 28:4635-4641
    • (2010) J Clin Oncol , vol.28 , pp. 4635-4641
    • Ludwig, H.1    Adam, Z.2    Hajek, R.3    Greil, R.4    Tóthová, E.5    Keil, F.6
  • 33
    • 77953826186 scopus 로고    scopus 로고
    • Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: Dosing of lenalidomide according to renal function and effect on renal impairment
    • Dimopoulos MA, Christoulas D, RoussouM, Kastritis E, Anagnostou D, Koureas A et al (2010) Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment. Eur J Haematol 85:1-5
    • (2010) Eur J Haematol , vol.85 , pp. 1-5
    • Dimopoulos, M.A.1    Christoulas, D.2    Roussou, M.3    Kastritis, E.4    Anagnostou, D.5    Koureas, A.6
  • 34
    • 77953862198 scopus 로고    scopus 로고
    • The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function
    • Dimopoulos M, Alegre A, Stadtmauer EA, Goldschmidt H, Zonder JA, de Castro CM et al (2010) The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function. Cancer 116:3807-3814
    • (2010) Cancer , vol.116 , pp. 3807-3814
    • Dimopoulos, M.1    Alegre, A.2    Stadtmauer, E.A.3    Goldschmidt, H.4    Zonder, J.A.5    De Castro, C.M.6
  • 35
    • 77949329927 scopus 로고    scopus 로고
    • Reversal of dialysis-dependent renal failure in patients with advanced multiple myeloma: Single institutional experiences over 8 years
    • Matsue K, Fujiwara H, Iwama KI, Kimura S, Yamakura M, Takeuchi M (2010) Reversal of dialysis-dependent renal failure in patients with advanced multiple myeloma: single institutional experiences over 8 years. Ann Hematol 89:291-297
    • (2010) Ann Hematol , vol.89 , pp. 291-297
    • Matsue, K.1    Fujiwara, H.2    Iwama, K.I.3    Kimura, S.4    Yamakura, M.5    Takeuchi, M.6
  • 36
    • 34547706021 scopus 로고    scopus 로고
    • Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents
    • DOI 10.3324/haematol.10759
    • Kastritis E, Anagnostopoulos A, Roussou M, Gika D, Matsuoka C, Barmparousi D et al (2007) Reversibility of acute renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimens and the impact of novel agents. Haematologica 92:546-549 (Pubitemid 350144300)
    • (2007) Haematologica , vol.92 , Issue.4 , pp. 546-549
    • Kastritis, E.1    Anagnostopoulos, A.2    Roussou, M.3    Gika, D.4    Matsouka, C.5    Barmparousi, D.6    Grapsa, I.7    Psimenou, E.8    Bamias, A.9    Dimopoulos, M.A.10
  • 37
    • 84885104232 scopus 로고    scopus 로고
    • Comparison of plasma exchange and hemodialysis using a high cut-off membrane (HCO) for removal of immunoglobulin free light chains in multiple myeloma
    • Wynckel A, Vuiblet V, Schneider N, Kolb B, Melin JP, Journet J et al (2010) Comparison of plasma exchange and hemodialysis using a high cut-off membrane (HCO) for removal of immunoglobulin free light chains in multiple myeloma. J Am Soc Nephrol 21:39A
    • (2010) J Am Soc Nephrol , vol.21
    • Wynckel, A.1    Vuiblet, V.2    Schneider, N.3    Kolb, B.4    Melin, J.P.5    Journet, J.6
  • 38
    • 53949120851 scopus 로고    scopus 로고
    • European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE). A randomised control trial
    • Hutchison CA, Cook M, Heyne N, Weisel KC, Billingham L, Bradwell A et al (2008) European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE). A randomised control trial. Trials 9:55
    • (2008) Trials , vol.9 , pp. 55
    • Hutchison, C.A.1    Cook, M.2    Heyne, N.3    Weisel, K.C.4    Billingham, L.5    Bradwell, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.